FOREST CITY ENTERPRISES/T CELL SCIENCES SC 13D

Company

Celldex Therapeutics, Inc.

Filed

November 25, 1997

Accession Number

0000950152-97-008307

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →